Methadone Patient Access to Collaborative Treatment

Part of paid clinical trials in Tucson, Arizona.

Sponsor
University of Arizona
Study ID
NCT06556602
Status
Recruiting

Conditions

  • Opioid Use Disorder
  • Patients
  • Staff

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • MPACT — OTHER
    Four components are part of this intervention: 1) accredited training about patient centered, trauma-informed care and the standard of care under the current federal regulation (42CFRpart8), 2) education about trauma and trauma symptoms including vicarious (work related) trauma and navigation to symptoms screening and resources including treatment, 3) reflective supervision for counseling, case management and peer staff, and 4) clinic self assessment for trauma-informed and patient centered care

Study Details

The trial of Methadone Patient Access to Collaborative Treatment (MPACT) will establish the impact of the intervention on patient outcomes of methadone treatment retention and in treatment overdose. It will also establish the impact of patient and staff trauma symptoms and clinic practice change on MPACT intervention implementation.

Key Dates

First listed
Aug 16, 2024
Start date
Feb 5, 2026
Status verified
Jul 2026
Primary completion
Apr 30, 2029
Completion
Jun 30, 2029

Study Design

Enrollment
1,080 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: MPACT Intervention
    Enrolled clinic staff will be exposed to the MPACT intervention components over the trial period. This includes accredited training, clinic self assessment, reflective supervision for counseling/peer/case management staff, and wellness education with navigation to trauma symptoms assessment and resources including trauma treatment. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.
  • No Intervention: Control for MPACT
    Enrolled clinic staff will not receive any portion of the intervention. Periodic surveys of staff and patients will be conducted to assess outcome measures (primary and secondary) and patient chart reviews will verify patient outcomes.

Primary Outcome Measure

Days in Treatment to treatment interruption [ Time Frame: 18 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Arizona College of NursingTucsonArizona85714
Beth Meyerson, PhD
520-626-0275
Beth Meyerson, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Tucson, AZ

Related Studies